
ã³ããã¯ã¯ãã³æ¥çš®åŸã®é倿çµ
欧å·å»è¬ååºïŒEMAïŒã«èšçœ®ãããŠããããã¡ãŒãã³ããžã©ã³ã¹ã»ãªã¹ã¯è©äŸ¡å§å¡äŒïŒPRACïŒãã¯ã10æ27æ¥ã®äŒè°ã§ãã¡ã€ã¶ãŒè£œãšã¢ãã«ã補ã®ã³ããã¯ã¯ãã³æ¥çš®ã«é¢ããŠãé »åºŠäžæã®å¯äœçšãšããŠé倿çµãè£œåæ å ±ã«è¿œèšããããã«å§åããŸããã
ã¯ã¯ãã³ãšå æé¢ä¿ãããå¯èœæ§
EUã®å»è¬åèŠå¶åœå±ã§ããEMAã«ã¯ãå®å šæ§æ¥åã®å¹çåãéææ§ãä¿é²ããããã«ãããã¡ãŒãã³ããžã©ã³ã¹ã»ãªã¹ã¯è©äŸ¡å§å¡äŒãïŒPharmacovigilanceãRiskãAssessmentãCommitteeïŒPRACïŒãèšçœ®ãããŠããŸãã10æ27æ¥ã«éå¬ãããPRACã®äŒè°ã§ããã¡ã€ã¶ãŒè£œãšã¢ãã«ã補ã®ã¯ã¯ãã³æ¥çš®åŸã®é倿çµã«ã€ããŠè©±ãåãããŸããããã®å 容ã¯ãäžèšã§ç¢ºèªã§ããŸãã
以äžãäžéšãåŒçšããŸãã
Comirnaty and Spikevax: heavy menstrual bleeding added as a side effect
Cases of heavy menstrual bleeding have been reported after the first, second and booster doses of Comirnaty and Spikevax.
ã³ãããã£ïŒãã¡ã€ã¶ãŒè£œïŒãšã¹ãã€ã¯ããã¯ã¹ïŒã¢ãã«ã補ïŒã®1åç®ã2åç®ãããŒã¹ã¿ãŒæäžåŸã«ãéãæçµåºè¡ã®çäŸãå ±åãããŠããŸãã
ããã®ã»ãšãã©ãæ·±å»ã§ãªããäžæçãªãã®ã§ãã£ãããšããªããããäžèšã®ããã«å€æããŠããŸãã
After reviewing the data, the Committee concluded that there is at least a reasonable possibility that the occurrence of heavy menstrual bleeding is causally associated with these vaccines and therefore recommended the update of the product information.
ããŒã¿ãæ€èšããçµæãå§å¡äŒã¯ãé倿çµã®çºçããããã®ã¯ã¯ãã³ãšå æé¢ä¿ãããåççãªå¯èœæ§ãå°ãªããšããããšå€æããè£œåæ å ±ã®æŽæ°ãå§åããŸããã
ã¯ã¯ãã³ãšé倿çµãé¢ä¿ããŠããå¯èœæ§ããããªããæçµäžé ãäžæ£åºè¡ãªã©ãšã®é¢ä¿ãå¯èœæ§ãããã®ã§ã¯ãªãã§ããããã
ããã©ããååŽçã®ãµã€ãã§ã¯ä»ãäžèšã®ããã«æžãããŠããŸãã

ãçŽæ¥çã«èµ·ããããšã¯ãªãããšããã®ãéãéãšããå°è±¡ã§ãããæµ·å€ã§æ°ããªå§åãåºãŠããã®ã«ããå¯èœæ§ããšããŠæ å ±ãæŽæ°ããªããŠããã®ã§ããããã
å¿ççã®ãšãããã¢ã¡ãªã«ã§æ¥çš®åŸã®çºçã2021幎4æé ããå ±åããããã®åŸæ°ã¶æçµã£ãŠããæ¥æ¬ã§ãèª¬ææžãæ·»ä»ææžã«è¿œèšãããŸããïŒäžèšåç §ïŒãé倿çµã«ã€ããŠãããã®ãããªæµãã«ãªãã®ã§ã¯ãªãã§ããããã
ååŽçãå ¬éããŠãããå¯åå¿çãã®å ±åãã§ããæçµç°åžžãäžæ£åºè¡ã®äºäŸã¯å€æ°ãããŸãã
äžèšã¯ãåæœ®åã®10æ³ã«èµ·ããäžæ£åºè¡ã®äºäŸã§ãã
åŠåš ãåºç£ã«åœ±é¿ã¯ãªãã®ãïŒ
é倿çµã«ã³ããã¯ã¯ãã³ãé¢ä¿ããŠãããšããããåŠåš ãåºç£ã«åœ±é¿ã¯ãªãã®ã§ããããã
PRACã®è³æã«ã¯ãäžèšã®ããã«æžããŠããŸãã
There is no evidence to suggest the menstrual disorders experienced by some people have any impact on reproduction and fertility.
äžéšã®äººãçµéšããæçµç°åžžããçæ®ãåèã«åœ±é¿ãäžããããšã瀺ããšããã³ã¹ã¯ãããŸããã
ããšããã³ã¹ããªãããšèšã£ãŠããã ãã§ããå æé¢ä¿ããªãããšã¯èšã£ãŠããŸããããŸã ãããããªãããšããããšã ãšæããŸããã¯ã¯ãã³æ¥çš®ãšé倿çµã®é¢ä¿ã§ãããåœåã¯èšãããŠããªãã£ãã®ã«ãä»ã«ãªã£ãŠå¯èœæ§ãããããšãæããã«ãªã£ãŠããã®ã§ããåŠåš ãåºç£ã«é¢ä¿ãããããšããåŸã«ãªã£ãŠæããã«ãªã£ãŠãããããããŸããã
å¯èœæ§ãç¥ããããŠããŠãããã§ãèªåã§æ±ºããŠæ¥çš®ããå Žåãšãå¯èœæ§ãç¥ããããã«æ¥çš®ããå Žåã§ã¯ã倧ããéããšæããŸãã人ã®å¥åº·ãåœã人çãå·Šå³ããæ å ±ãªã®ã«ããªãååŽçã¯ããã«ã¢ããããŒãããŠãåšç¥ãããªãã®ã§ããããã